Free Stock Alerts - (NASDAQ:APCVZ) Is Today’s Top Percentage Mover

Those investors who are planning to make money in the penny stock market should subscribe to FREE Alerts by visiting: http://www.pennystockpickreport.com/

Fresenius Kabi Pharmaceuticals Hldg Inc (NASDAQ:APCVZ) rallied over 60% to $0.82 in morning trade on massive volume of 2.5 million shares after APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Sumatriptan Succinate Injection, USP, in two dosage strengths. Sumatriptan Succinate Injection is therapeutically equivalent to the reference-listed drug Imitrex®, which is marketed by the innovator GlaxoSmithKline. APP will package Sumatriptan Succinate Injection in pre-filled syringes of 4 mg (base) /0.5 mL and 6 mg (base) / 0.5 mL. In February 2009, APP received approval for Sumatriptan Succinate for Injection, USP packaged in single dose vials of 6 mg / 0.5 mL.

The stock has traded within a 52-week range of $0.18 and $1.82. In the last six months the stock has rallied over 233%.

ABOUT PennyStockPickReport.com

www.pennystockpickreport.com is one of the leading stock web site that provides free stock alerts and tracks small cap penny stocks that could be on the brink of a massive breakout.  If you wish to get your company featured on our website then please contact us at info @PennyStockPickReport.com